
Glow70 (TB-500 + BPC-157 + GHK)
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
Glow70 is a research blend combining three peptides in a single vial — TB-500, BPC-157 and GHK — pairing two of the most studied tissue-repair peptides with a copper-binding skin-remodeling peptide. It is formulated for research that examines recovery and dermal signaling together.
| Test | Result | Status |
|---|---|---|
| Purity | 99.7% | Passed ✓ |
Research Information
Glow70 is used to study the combined effects of actin-regulating (TB-500), cytoprotective and angiogenic (BPC-157) and matrix-remodeling (GHK) peptides on tissue regeneration, wound healing and dermal collagen signaling in laboratory models, and whether the components act complementarily. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
Glow70 (TB-500 + BPC-157 + GHK) Research & Studies
What is Glow70?
Glow70 is a laboratory research blend that combines three peptides—TB-500, BPC-157, and GHK—in a single vial. It is designed for experimental systems that examine tissue regeneration, wound-related signaling, and dermal matrix remodeling together rather than in isolation. Each component has been studied independently for distinct molecular pathways, and the blend enables investigation of whether their activities may act in a complementary manner under controlled in-vitro and laboratory conditions. Glow70 is supplied strictly for research use only and is not intended for human or animal consumption.
Mechanism of Action
TB-500 is investigated primarily for its role in actin sequestration and regulation of cytoskeletal dynamics that influence cell migration in culture models. BPC-157 has been examined for cytoprotective and angiogenic signaling pathways, including interactions with growth-factor cascades in laboratory systems. GHK is studied as a matrix-remodeling peptide that can modulate collagen- and extracellular-matrix-related gene expression and copper-binding activity in dermal and fibroblast models. Together, these mechanisms allow researchers to probe overlapping recovery and structural-remodeling pathways in experimental settings.
Primary Areas of Research
Glow70 is used in research focused on tissue regeneration, wound-healing cascades, and dermal collagen signaling within laboratory models. Investigators may evaluate how actin-regulating, cytoprotective-angiogenic, and matrix-remodeling peptides influence cell migration, vascular-related markers, and extracellular-matrix organization when studied in combination. Experimental designs often compare the blend against single-peptide arms to assess potential complementarity. All such work remains confined to in-vitro assays and controlled laboratory research systems.
Key Research Findings on Components
Published laboratory work on TB-500 has linked it to actin binding and enhanced migratory behavior of cells in wound-model assays. BPC-157 has been documented in experimental systems for effects on angiogenic markers and cytoprotection under stress conditions. GHK has been characterized for its ability to influence expression of genes involved in collagen synthesis, matrix metalloproteinases, and tissue remodeling in cultured skin-related cells. These component-level observations form the scientific basis for studying the three peptides together in multi-pathway regeneration models.
Research Handling and Considerations
Glow70 should be handled according to standard peptide laboratory practices, including appropriate storage, reconstitution with suitable research-grade solvents, and protection from repeated freeze-thaw cycles. Researchers must document lot-specific concentrations and maintain sterile technique when preparing working solutions for cell culture or biochemical assays. The blend is intended solely for in-vitro and laboratory research; it is not for human or animal use. Institutional biosafety and chemical-handling guidelines apply to all experimental procedures involving this material.
Frequently Asked Questions
Glow70 is a research blend containing TB-500, BPC-157, and GHK in a single vial for laboratory investigation of combined tissue-repair and dermal-signaling pathways.
Explore Other High-Purity Peptides

Klow80 (TB-500 + BPC-157 + GHK + KPV)

BPC-157 + TB-500 Blend

Cagrilintide + Semaglutide Blend
